These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Comparative Study on Effect of Rabeprazole Versus Omeprazole in Acid-peptic Disorder with Helicobacter pylori Infection. Gurung SB; Kc SR; Gyawali P; Amatya GL J Nepal Health Res Counc; 2020 Jan; 17(4):479-484. PubMed ID: 32001852 [TBL] [Abstract][Full Text] [Related]
46. Speed of onset of oesophageal acid reduction with different proton-pump inhibitors in patients with reflux oesophagitis. Newton M; Burnham WR; Kamm MA Eur J Gastroenterol Hepatol; 1998 Sep; 10(9):753-8. PubMed ID: 9831269 [TBL] [Abstract][Full Text] [Related]
47. Maintenance treatment with proton pump inhibitors for reflux esophagitis in pediatric patients: a systematic literature analysis. Illueca M; Wernersson B; Henderson C; Lundborg P J Pediatr Gastroenterol Nutr; 2010 Dec; 51(6):733-40. PubMed ID: 20808247 [TBL] [Abstract][Full Text] [Related]
48. Is omeprazole helpful in the management of children with reflux oesophagitis? Varughese LA; Mazur LJ Arch Dis Child; 2002 Jul; 87(1):78-80. PubMed ID: 12089134 [No Abstract] [Full Text] [Related]
49. Spontaneous resolution of euthyroid optic neuropathy. Kitaguchi Y; Ishihara K; Nishida K Can J Ophthalmol; 2019 Aug; 54(4):e188-e192. PubMed ID: 31358166 [No Abstract] [Full Text] [Related]
50. Characteristics of refractory gastroesophageal reflux disease (GERD) symptoms -is switching proton pump inhibitors based on the patient's CYP2C19 genotype an effective management strategy? Takeuchi T; Oota K; Harada S; Edogawa S; Kojima Y; Sanomura M; Sakaguchi M; Hayashi K; Hongoh Y; Itabashi T; Kitae H; Hoshimoto M; Takeuchi N; Higuchi K Intern Med; 2015; 54(2):97-105. PubMed ID: 25742999 [TBL] [Abstract][Full Text] [Related]
51. Staying healthy while using PPIs. Be mindful of risks for fracture, low B12, and a spike in stomach acid. Harv Health Lett; 2015 Feb; 40(4):7. PubMed ID: 26223055 [No Abstract] [Full Text] [Related]
52. Proton Pump Inhibitor-Associated C. difficile Infection in a Peritoneal Dialysis Patient. Ziolkowski SL; Malabanan MH; Liebman SE Perit Dial Int; 2015; 35(5):586-7. PubMed ID: 26450478 [No Abstract] [Full Text] [Related]
53. [Factors affecting efficacy of gastroesophageal reflux disease treatment with proton pump inhibitors]. Ter Arkh; 2012; 84(2):16-21. PubMed ID: 22715656 [TBL] [Abstract][Full Text] [Related]
55. The efficacy and safety of proton-pump inhibitors in treating patients with non-erosive reflux disease: a network meta-analysis. Chen L; Chen Y; Li B Sci Rep; 2016 Sep; 6():32126. PubMed ID: 27581096 [TBL] [Abstract][Full Text] [Related]
56. Effect of wu chu yu tang on gastroesophageal reflux disease: Randomized, double-blind, placebo-controlled trial. Shih YS; Tsai CH; Li TC; Yu CJ; Chou JW; Feng CL; Wang KT; Lai HC; Hsieh CL Phytomedicine; 2019 Mar; 56():118-125. PubMed ID: 30668332 [TBL] [Abstract][Full Text] [Related]